The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 20, No. 12, pp. 964-967.
© 1986 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauser, V.
Right arrow Articles by Rozek, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauser, V.
Right arrow Articles by Rozek, S.


Research Articles

Effect of warfarin on the activated partial thromboplastin time

VM Hauser and SL Rozek

Outpatients followed in an anticoagulation clinic were studied retrospectively to determine the effect of warfarin on the activated partial thromboplastin time (APTT). Twenty-nine patients were studied in part 1 of the trial to determine whether their APTT values were elevated when their prothrombin time (PT) was within 1.5 to 2.5 times the control PT. Part 2 was carried out using the data of 32 patients to determine whether a correlation existed between the degree of elevation of the patients' PT values due to warfarin and the concurrent degree of elevation of their APTT results. Baseline PT and APTT values and a minimum of three concurrent PT and APTT values determined during anticoagulation therapy with warfarin were used. Data were collected by chart review and review of Hematology Department records. Results indicated that a statistically significant difference was evident between the baseline APTT (30.79 sec) and the mean APTT (55.10 sec) when the PT was within the therapeutic range of 1.5 to 2.5 times the control while on warfarin therapy. Good linear correlation was evident (r = 0.821) between the degree of elevation of the PT and the degree of elevation of the APTT for the group. In most cases, a good linear correlation was also evident for individual patients. Routine ordering of concurrent APTT and PT tests for patients receiving warfarin therapy is not needed since the PT alone can be monitored under most circumstances.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
C. Kearon, M. Johnston, K. Moffat, J. McGinnis, and J. S. Ginsberg
Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin
Arch Intern Med, May 25, 1998; 158(10): 1140 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
T. Hodgman
A Review of Common Approaches to Heparin Dosing
Journal of Pharmacy Practice, February 1, 1995; 8(1): 39 - 46.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1986 by Harvey Whitney Books Company.